"V\u00FDsledky v t\u00E9to pr\u00E1ci jsou kalkulov\u00E1ny na z\u00E1klad\u011B diagnosticko-terapeutick\u00FDch algoritm\u016F, tedy procesn\u00EDch map. Ty vych\u00E1zej\u00ED z doporu\u010Den\u00FDch l\u00E9\u010Debn\u00FDch postup\u016F, kter\u00E9 vydal Masaryk\u016Fv onkologick\u00FD \u00FAstav, Fakultn\u00ED nemocnice v Hradci Kr\u00E1lov\u00E9 a Fakultn\u00ED nemocnice v Plzni. Celkov\u011B byly vy\u010D\u00EDsleny n\u00E1klady a \u00FAhrady pro 32 pou\u017E\u00EDvan\u00FDch algoritm\u016F, tj. procesn\u00EDch map. N\u00E1klady na l\u00E9\u010Debn\u00E9 procesy tvo\u0159\u00ED 22 v\u00FDsledk\u016F a diagnostick\u00FDm proces\u016Fm odpov\u00EDd\u00E1 10 v\u00FDsledk\u016F. P\u0159i jednotliv\u00FDch kalkulac\u00EDch byly zapo\u010Dteny p\u0159\u00EDm\u00E9 i nep\u0159\u00EDm\u00E9 n\u00E1klady. Z proveden\u00FDch kalkulac\u00ED vypl\u00FDv\u00E1, \u017Ee n\u00E1klady l\u00E9\u010Dby se v\u00FDrazn\u00FDm zp\u016Fsobem odli\u0161uj\u00ED v z\u00E1vislosti na zvolen\u00E9m diagnostick\u00E9m a terapeutick\u00E9m postupu. Ukazuje se, \u017Ee nastaven\u00ED syst\u00E9mu \u00FAhrad v sou\u010Dasn\u00E9 dob\u011B vytv\u00E1\u0159\u00ED rozd\u00EDln\u00E9 stimuly pro poskytovatele, kte\u0159\u00ED mohou realizovat jak kladn\u00E9, tak i z\u00E1porn\u00E9 saldo. Tato skute\u010Dnost pak m\u016F\u017Ee m\u00EDt vliv na hospod\u00E1\u0159sk\u00FD v\u00FDsledek a ve sv\u00E9m d\u016Fsledku v\u00E9st k preferenci \u00FAhradov\u011B v\u00FDhodn\u011Bj\u0161\u00EDch alternativ bez ohledu na optim\u00E1ln\u00ED postupy pro konkr\u00E9tn\u00EDho pacienta. Na tuto skute\u010Dnost do jist\u00E9 m\u00EDry reaguj\u00ED \u00FAhrady kalkulovan\u00E9 pomoc\u00ED syst\u00E9mu DRG."@cs . "\u0160imrov\u00E1, Jana" . "Anal\u00FDza n\u00E1klad\u016F a \u00FAhrad l\u00E9\u010Dby karcinomu plic v \u010Cesk\u00E9 republice" . "1"^^ . . "V\u00FDsledky v t\u00E9to pr\u00E1ci jsou kalkulov\u00E1ny na z\u00E1klad\u011B diagnosticko-terapeutick\u00FDch algoritm\u016F, tedy procesn\u00EDch map. Ty vych\u00E1zej\u00ED z doporu\u010Den\u00FDch l\u00E9\u010Debn\u00FDch postup\u016F, kter\u00E9 vydal Masaryk\u016Fv onkologick\u00FD \u00FAstav, Fakultn\u00ED nemocnice v Hradci Kr\u00E1lov\u00E9 a Fakultn\u00ED nemocnice v Plzni. Celkov\u011B byly vy\u010D\u00EDsleny n\u00E1klady a \u00FAhrady pro 32 pou\u017E\u00EDvan\u00FDch algoritm\u016F, tj. procesn\u00EDch map. N\u00E1klady na l\u00E9\u010Debn\u00E9 procesy tvo\u0159\u00ED 22 v\u00FDsledk\u016F a diagnostick\u00FDm proces\u016Fm odpov\u00EDd\u00E1 10 v\u00FDsledk\u016F. P\u0159i jednotliv\u00FDch kalkulac\u00EDch byly zapo\u010Dteny p\u0159\u00EDm\u00E9 i nep\u0159\u00EDm\u00E9 n\u00E1klady. Z proveden\u00FDch kalkulac\u00ED vypl\u00FDv\u00E1, \u017Ee n\u00E1klady l\u00E9\u010Dby se v\u00FDrazn\u00FDm zp\u016Fsobem odli\u0161uj\u00ED v z\u00E1vislosti na zvolen\u00E9m diagnostick\u00E9m a terapeutick\u00E9m postupu. Ukazuje se, \u017Ee nastaven\u00ED syst\u00E9mu \u00FAhrad v sou\u010Dasn\u00E9 dob\u011B vytv\u00E1\u0159\u00ED rozd\u00EDln\u00E9 stimuly pro poskytovatele, kte\u0159\u00ED mohou realizovat jak kladn\u00E9, tak i z\u00E1porn\u00E9 saldo. Tato skute\u010Dnost pak m\u016F\u017Ee m\u00EDt vliv na hospod\u00E1\u0159sk\u00FD v\u00FDsledek a ve sv\u00E9m d\u016Fsledku v\u00E9st k preferenci \u00FAhradov\u011B v\u00FDhodn\u011Bj\u0161\u00EDch alternativ bez ohledu na optim\u00E1ln\u00ED postupy pro konkr\u00E9tn\u00EDho pacienta. Na tuto skute\u010Dnost do jist\u00E9 m\u00EDry reaguj\u00ED \u00FAhrady kalkulovan\u00E9 pomoc\u00ED syst\u00E9mu DRG." . . "[882DFAB01F47]" . "21460" . "RIV/68407700:21460/13:00213734!RIV14-MZ0-21460___" . . "lung cancer; COI; reimbursements; costs"@en . . . "4"^^ . "P(NT11532)" . "RIV/68407700:21460/13:00213734" . . "OBJECTIVES: Lung cancer is the most frequently diagnosed oncologic disease worldwide, annually diagnosed in nearly 1.4 million patients. In 2010, the incidence in men was 89.7 per hundred thousand people (in 1996, it was 102.3), while in women 35.2 (against 22.9 in 1996). The severity of the disease is also reflected by the high mortality rate, which was 74.8 per hundred thousand people in men and 27.4 in women in 2010. METHODS: Identifying the costs spent by a clinic/hospital is difficult in the Czech Republic, as the majority of hospitals work with cost related data in the \u201Cconfidential\u201D mode. The costs were estimated and verified based on expert opinions of pulmonologists, oncologists, head physicians and staff members of technical and economic departments of five pneumo-oncologic centres and university hospitals in this study. RESULTS: Totally 32 procedures (process maps) were identified in lung cancer treatment (10 in diagnostic, 22 in therapeutic processes). Each procedure consists of diagnostics, therapy and subsequent monitoring of patients. Costs for respective steps were assessed, and total costs for each therapeutic scheme were calculated. CONCLUSIONS: The calculations imply that treatment costs significantly differ depending on the selected diagnostic/ therapeutic procedure. The setting of the reimbursement system generates different stimuli for providers who may reach both positive and negative balances. This fact may have an effect on economic results leading, in its consequence, to the preference of alternatives more suitable in terms of reimbursement regardless of the optimum procedures for a specific patient."@en . . . "Anal\u00FDza n\u00E1klad\u016F a \u00FAhrad l\u00E9\u010Dby karcinomu plic v \u010Cesk\u00E9 republice"@cs . "Bart\u00E1k, M." . "Vojt\u00ED\u0161ek, R." . "Anal\u00FDza n\u00E1klad\u016F a \u00FAhrad l\u00E9\u010Dby karcinomu plic v \u010Cesk\u00E9 republice" . . . "THE ANALYSIS OF COSTS AND REIMBURSEMENTS FOR LUNG CANCER TREATMENT IN THE CZECH REPUBLIC"@en . . . . . "THE ANALYSIS OF COSTS AND REIMBURSEMENTS FOR LUNG CANCER TREATMENT IN THE CZECH REPUBLIC"@en . . "Rogalewicz, Vladim\u00EDr" . . "60937" . . "Anal\u00FDza n\u00E1klad\u016F a \u00FAhrad l\u00E9\u010Dby karcinomu plic v \u010Cesk\u00E9 republice"@cs .